Skip to main content
. Author manuscript; available in PMC: 2011 Sep 14.
Published in final edited form as: JAMA. 2000 Feb 9;283(6):763–770. doi: 10.1001/jama.283.6.763

Table 2.

Serum Total and Free Testosterone, Luteinizing Hormone and Follicle-Stimulating Hormone, and Sex Hormone–Binding Globulin Levels*

No Exercise
Exercise
Placebo Testosterone Placebo Testosterone
Testosterone, nmol/L
 Baseline 6.1 (0.7) 7.1 (0.8) 7.0 (1.0) 7.0 (1.2)

 Week 16 5.0 (0.5) 11.7 (1.6) 7.4 (1.2) 10.8 (1.9)

 Change from baseline −1.2 (0.6) 4.5 (1.8)§ 0.4 (1.0) 3.8 (2.1)§

P value .06 .03 .62 .05

Free testosterone, pmol/L
 Baseline 100.5 (13.9) 111.0 (13.9) 117.9 (17.3) 93.6 (13.9)

 Week 16 107.5 (20.8) 183.8 (24.2) 121.4 (13.9) 166.4 (20.8)

 Change from baseline 1.0 (24.2) 72.8 (27.7) 3.5 (13.9) 69.3 (20.8)

P value .70 .02 .57 .02

Luteinizing hormone, U/L||
 Baseline 5.0 (1.0) 3.4 (0.4) 4.3 (0.9) 6.6 (2.0)

 Week 16 3.7 (0.8) 0.3 (0.1) 4.6 (1.0) 0.6 (0.3)

 Change from baseline −1.4 (0.7) −3.1 (0.4)§ 0.3 (0.2) −6.0 (1.8)§

P value .17 ,.001 .39 ,.001

Follicle-stimulating hormone, U/L||
 Baseline 5.8 (1.8) 4.5 (0.5) 7.1 (1.9) 8.6 (2.6)

 Week 16 5.0 (2.0) 0.5 (0.2) 6.7 (1.6) 2.0 (1.2)

 Change from baseline −0.8 (0.8) −4.2 (0.4) −0.4 (0.7) −6.5 (1.6)

P value .20 ,.001 .71 ,.001

Sex hormone–binding globulin, nmol/L
 Baseline 66.4 (12.1) 48.6 (8.8) 52.0 (12.9) 47.5 (8.3)

 Week 16 63.7 (16.8) 41.7 (7.0) 49.1 (9.5) 41.7 (8.9)

 Change from baseline −2.7 (8.3) −6.9 (3.1) −2.9 (3.8) −5.8 (2.4)

P value .75 .05 .46 .05
*

The data represent the mean (SEM) of all available values on that day. However, the change represents the difference between paired values only.

Overall analysis of variance is P<.03.

To convert total testosterone levels to nanograms per deciliter, multiply by 28.843. To convert free testosterone levels to picograms per milliliter, multiply by 0.28843.

§

P<.05 vs placebo, no exercise.

||

Overall analysis of variance, P<.001.

P<.05 vs placebo, no exercise, and placebo with exercise.